These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37065474)

  • 1. Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis.
    Yan J; Ye G; Shao Y; Zhou H
    Front Genet; 2023; 14():1158341. PubMed ID: 37065474
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
    Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
    Front Surg; 2022; 9():836080. PubMed ID: 35392063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment.
    Pu Z; Liu J; Liu Z; Peng F; Zhu Y; Wang X; He J; Yi P; Hu X; Fan X; Chen J
    Cancer Cell Int; 2022 Oct; 22(1):314. PubMed ID: 36224658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
    Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
    Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma.
    Liu Y; Jiang Z; Zhou X; Li Y; Liu P; Chen Y; Tan J; Cai C; Han Y; Zeng S; Shen H; Feng Z
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835825
    [No Abstract]   [Full Text] [Related]  

  • 9. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
    Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
    Front Oncol; 2021; 11():766072. PubMed ID: 34868990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 11. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.
    Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y
    Front Surg; 2022; 9():878648. PubMed ID: 36211267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
    Wang B; Tang D; Zhang Z; Wang Z
    J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study.
    Zhang J; Fu X; Zhang N; Wang W; Liu H; Jia Y; Nie Y
    Ann Transl Med; 2022 May; 10(9):524. PubMed ID: 35928748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma.
    Xu Q; Hu Y; Chen S; Zhu Y; Li S; Shen F; Guo Y; Sun T; Chen X; Jiang J; Huang W
    Front Mol Biosci; 2021; 8():683240. PubMed ID: 34124163
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.
    Wang J; Ling S; Ni J; Wan Y
    BMC Cancer; 2022 Jun; 22(1):638. PubMed ID: 35681134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation.
    Guan R; Zou J; Mei J; Deng M; Guo R
    BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
    Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
    Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.